Diagnostic and Medical Device
- Cross-sectional, Prospective,
Retrospective-prospective - Hypothesis-generating and hypothesis-validating
- Case-Cohort, Case-Control and Nested Case-Control
- Pilot and pivotal studies for regulatory submissions
- Regulatory Class I, II and III; in vitro diagnostics, Investigational Device Exemptions (IDE); CLIA Waiver, and Point-of-Care
Pharmaceutical
- Phase I Pharmacokinetic and Pharmacodynamic
- Phase I dose-finding, safety and tolerability
- Phase IIa
- Phase IIb
- Phase III
- Phase IV
- Topical, oral, injectable dosage forms
- Oncology
- Urology
- Cardiovascular disease
- Neurological disorders
- Diabetes
- Non-invasive pre-natal diagnostics
- Infectious diseases
- Asthma and Pulmonology
- Metabolic bone disease
- Cognitive impairment
- CRISPR Immuno-oncology
- Gastroenterology
- Rheumatology
- Endocrinology
- Fertility
- Dermatology/Dermatologic surgery
- Obesity
- Orphan Diseases
- Palliative and Managed Care
- Pediatrics